Document Detail


A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients.
MedLine Citation:
PMID:  24717379     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: Because randomized clinical trials in bipolar disorder include restricted study populations, the possibilities for generalizing to real-world bipolar patients are limited. Naturalistic long-term data can add valuable information about the diversity of treatment and outcome in bipolar disorder.
METHOD: After discharge from a psychiatric community hospital, 300 consecutively admitted patients with ICD-10 bipolar I (n = 158) and II (n = 142) disorder were followed up naturalistically for 4 years. Patients were assessed with regard to time to relapse, relapse polarity in relation to index episode, prophylactic effects of prescribed medication, prescribing behaviors, and medication adherence. Drugs were chosen by the treating psychiatrists on the basis of clinical judgment. Prescribed medications included lithium, carbamazepine, valproate, lamotrigine, antidepressants, and atypical antipsychotics, all of which were compared as a single mood stabilizer or in combination with at least 2 prophylactic agents. The study was conducted from 2000 through 2008.
RESULTS: 204 of 300 patients (68%) relapsed within 4 years, with a mean of 208 days (SD = 356.2) until the next affective episode. Relapses correlated in a statistically significant manner with the index episode (χ24 = 57.48, P = .000; bipolar I: χ24 = 20.19, P = .000; bipolar II: χ24 = 106.82, P = .000). A Kaplan survival analysis showed that lithium in monotherapy statistically significantly delayed time to the next affective relapse (P = .002). Survival (time to relapse) was also statistically significantly reduced when prophylactic medication was changed by the psychiatrist (P = .000) or stopped by the patient (P = .001). In general, no differences in tested parameters were seen between the bipolar I and II groups.
CONCLUSIONS: Our data confirm a high risk of relapse in a naturalistic setting. Lithium seems to offer some advantage over other medication over the long-term treatment of bipolar I and II disorder. Patients tend to relapse with the same polarity as their index episode; this emphasizes the importance of the polarity concept. Changing of medications by the psychiatrist and stopping of medication by the patient appear to be risk factors for an earlier affective relapse.
TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01792128.
Authors:
Christian Simhandl; Barbara König; Benedikt L Amann
Related Documents :
24554809 - Atrioventricular septal defect with common atrioventricular junction guarded by a commo...
25301039 - Defining the structure of undergraduate medical leadership and management teaching and ...
21226569 - Residents: workers or students in the eyes of the law?
25180919 - Resuscitating two birds with one stone; improving ambulance response times and enhancin...
25386509 - Question vetting: the process to ensure quality in assessment of medical students.
23539769 - Value-based insurance design yields near- and long-term improvements in medication adhe...
1113279 - A new type of facility in medical education: the clinical learning center.
8607779 - John north: multiple skilled general practitioner.
21609149 - Two serious and challenging medical complications associated with volatile substance mi...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of clinical psychiatry     Volume:  75     ISSN:  1555-2101     ISO Abbreviation:  J Clin Psychiatry     Publication Date:  2014 Mar 
Date Detail:
Created Date:  2014-04-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7801243     Medline TA:  J Clin Psychiatry     Country:  United States    
Other Details:
Languages:  eng     Pagination:  254-63     Citation Subset:  IM    
Copyright Information:
© Copyright 2014 Physicians Postgraduate Press, Inc.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Trends in office-based mental health care provided by psychiatrists and primary care physicians.
Next Document:  Misdiagnosis of bipolar depression in primary care practices.